BioScrip (BIOS) Misses Q2 EPS by 5c

August 8, 2016 6:54 AM EDT
Get Alerts BIOS Hot Sheet
Trade BIOS Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

BioScrip (NASDAQ: BIOS) reported Q2 EPS of ($0.14), $0.05 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $232.5 million versus the consensus estimate of $229.58 million.

GUIDANCE:

BioScrip sees FY2016 EPS of ($0.48)-($0.38).

For earnings history and earnings-related data on BioScrip (BIOS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment